GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
76 hedge funds and large institutions have $124M invested in GALENA BIOPHARMA INC COM in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 21 reducing their positions, and 14 closing their positions.
205% more capital invested
Capital invested by funds: $40.7M → $124M (+$83.6M)
59% more call options, than puts
Call options by funds: $17M | Put options by funds: $10.7M
43% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 21
21% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 14
4% more funds holding
Funds holding: 73 → 76 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$20.4M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$14.8M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
+$1.55M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$1.24M |
| 5 |
Morgan Stanley
New York
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.6M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$855K |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$793K |
| 4 |
Goldman Sachs
New York
|
-$785K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$717K |
RXII Hedge Fund Activity: Q4 2013 in Review
76 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q4 2013, worth a combined $124M — up 205% from $40.7M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new RXII positions and 14 closed out — a net gain of 3 holders — while 30 added to existing stakes and 21 trimmed.
The largest buyer was State Street, adding an estimated $20.4M. The largest seller was Highland Capital Management (Texas), cutting an estimated $2.6M.
- 76 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q4 2013, up from 73 in Q3 2013.
- Funds reported $124M of GALENA BIOPHARMA INC COM stock for Q4 2013, up 205% quarter-over-quarter.
- 17 funds opened new GALENA BIOPHARMA INC COM positions in Q4 2013 and 14 closed out, a net change of +3 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q4 2013 was State Street, an estimated $20.4M added.
- The largest GALENA BIOPHARMA INC COM seller in Q4 2013 was Highland Capital Management (Texas), an estimated $2.6M sold.
Based on aggregated 13F filings for Q4 2013.